Document:

EX-10.9

  DocuSign Envelope ID: C7648EEF-BCE5-48C4-B78C-E3D684BB9F7F

  Exhibit 10.9

  		
	 
	Mind Medicine, Inc.  
One World Trade Center, Suite 8500
New York, NY 10007

   

  Cynthia Hu

  XXXXXXXXXX
XXXXXXXXX

   

  VIA E-MAIL XXXXXXXXXX

  November 23, 2021 (as modified November 29, 2021)

   

  Re:  Offer of Employment - Chief Legal Officer & Corporate Secretary

   

  Dear Cynthia:

   

  Mind Medicine, inc. (the “Company”) is please to offer you employment with the Company, on the terms described below. 

   

  1.Position.  You will start in a full-time position as Chief Legal Officer & Corporate Secretary which reports directly to Company’s Chief Executive Officer and with a dotted line to the Company’s Board of Directors. This offer is made on the following terms. Your position is remote-based. Your work will be based out of your home in XXXXXXXXXX. However, you will be expected to make such business trips to such places as may be necessary or advisable for the efficient operations of the Company. By signing this letter, you confirm with the Company that you are under no contractual or other legal obligations that would prohibit you from performing your duties with the Company. 

   

  2.Compensation.  Your full-time base cash salary will be at the rate of $365,000 per year, payable on the Company’s regular payroll dates, subject to tax and other withholdings as required by law. You will also be eligible for an annual bonus of up to 40% of your then current base cash salary accrued on a daily basis. The annual bonus, if any, will be determined by the Board of Directors of the Company in its sole discretion. If your employment is terminated by either you or the Company for any reason prior to the date bonuses are awarded to you based on an annual performance review, you are not eligible for a bonus, prorated or otherwise. 

  You shall receive a one-time signing bonus to be paid on a date to be determined by the Company, which date shall ordinarily be no later than 21 days after you commence employment with the Company, or as soon thereafter as is practicable. The signing bonus shall be in the amount of $40,000 (less payroll deductions and all required withholdings). You will earn, and be permitted to retain, the full amount of the signing bonus if you remain  employed by the Company through one (1) year anniversary of your start date. By signing below, you acknowledge and agree that, if before such one (1) year anniversary date, your employment terminates for any reason, you will be required to immediately re-pay a pro-rata portion of the 

  OL 2021.11.23

  

  DocuSign Envelope ID: C7648EEF-BCE5-48C4-B78C-E3D684BB9F7F

  signing bonus (with such pro-rata amount based on the number of days employed during such one year period). 

   

  Your employment is subject to the Company’s personnel policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company’s sole discretion. You will be eligible to participate on the same basis as similarly-situated employees in the Company’s benefit plans in effect from time to time during your employment. All matters of eligibility for coverage or benefits under any benefit plan shall be determined in accordance with the provisions of such plan.  The Company reserves the right to change, alter, or terminate any benefit plan in its sole discretion. 

   

  3.Payroll and Equity Compensation.  You will be paid on the Company’s regular payroll dates (currently semi-monthly) and you will be eligible for standard Company benefits relating to medical insurance, vacation, sick leave, and holidays, as they become available. The Company may modify compensation and benefits from time to time as it deems necessary, provided however, in no event shall the annual base salary be less than $365,000, unless mutually agreed. You will also be eligible to participate in the company’s stock option plan and performance and restricted unit plan, the details of which will be decided by the Compensation Committee of the Board of Directors. 

   

  4.Options Grant and Restricted Stock Units. You will also be eligible to participate in the Company’s stock option plan and performance and restricted stock unit plan. I will recommend to the Board or Directors of the Company that you be granted: (i) an option to purchase shares of the Company’s common stock (“Option”), and (ii) a right to receive restricted stock units of the Company (“RSUs”). As you know, the Company and its Compensation Committee are in the process of conducting an executive compensation review and has retained a third-party compensation consulting firm, Compensia, to conduct this analysis.  The amounts of both the Option and RSU equity grants will be determined based on the outcome of this analysis. The total dollar value of equity grants will be in line with the Company’s peers and in accordance with the Company’s Compensation Committee’s determinations as they relate to executive compensation.  These will need to be approved by the Board of Directors. 

   

  The Option will vest as follows: 25% of the shares on the first anniversary of your employment, 1/36th of the remaining shares per month thereafter over 36 months. The RSUs will vest as follows: 25% of the units on the first anniversary of your employment, 1/36th of the remaining units per month thereafter over 36 months. The Option and the RSUs are subject to applicable Grant Agreements as well as Company’s Stock option plan and Performance and Restricted Unit Plan, respectively.

   

  5.Proprietary Information and Inventions Agreement.  As a Company employee, you will be expected to abide by Company rules and regulations and sign and comply with the attached Proprietary Information and Inventions Agreement which prohibits unauthorized use or disclosure of Company proprietary information. In your work for the Company, you will be expected not to use or disclose any confidential information, including trade secrets, of any former employer or other people to whom you have the obligation of confidentiality. Rather, you will be expected to use only that information which is generally known and used by persons with 

  OL 2021.11.23

  

  DocuSign Envelope ID: C7648EEF-BCE5-48C4-B78C-E3D684BB9F7F

  training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. You agree that you will not bring onto Company premises any unpublished documents or property belonging to any former employer or other person to whom you have an obligation of confidentiality. 

   

  6.Work Site.  The Company maintains highly flexible working conditions. Your status will be as an exempt, salaried employee and you will not be placed on a fixed work schedule but will be expected to be available as required by the nature of your work assignments. 

   

  7.At Will Employment.  Employment with the Company is for no specific period of time. Your employment with the Company will be “at will,” meaning that either you or the Company may terminate your employment at any time and for any reason, with or without cause. Any contrary representations which you believe  may have been made to you are superseded by this offer.  This is the full and complete agreement between you and the Company on this term.  Although your job duties, title, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and the Company’s Chief Executive Officer. 

   

  8.Additional Agreements.  As a condition of your employment, you agree to execute any additional agreements required by the Company at the start of your employment. This includes any agreements that relate to your confidentiality or intellectual property assignment obligations to the Company. You further agree that at all times during your employment (and afterward as applicable), you will be bound by, and will fully comply with, these additional agreements. 

   

  9.Contingencies. This offer is contingent upon the successful completion of any background or reference checks desired by the Company. For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to us within three business days following the start of your employment, or our employment relationship with you may be terminated. 

  Subject to approval of the Board, following completion of its work with the compensation consulting firm, the Board will make an equity grant to you in connection with your new Employment Agreement. The specific type of equity, terms, conditions and vesting schedule will be as set forth in the Company’s then effective equity plan and applicable grant documents.

   

  You will have the opportunity to review any public disclosures, announcement, and/or SEC filings, if applicable, in connection with your joining the Company. 

   

  10.Miscellaneous.

  (a)Entire Agreement. This letter sets forth the entire agreement and understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, understandings and agreements, whether oral or written, between them relating to the subject matter hereof.  

  OL 2021.11.23

  

  DocuSign Envelope ID: C7648EEF-BCE5-48C4-B78C-E3D684BB9F7F

  (b)Counterparts.  This letter may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and all of which together shall constitute one and the same agreement.   Execution via DocuSign (or similar online execution platform), facsimile copy or scanned image will have the same force and effect as execution of an original, and a DocuSign, facsimile signature or scanned image will be deemed an original and valid signature. 

  (c)Governing Law. The terms of this letter agreement and the resolution of any disputes as to the meaning, effect, performance or validity of this letter agreement or arising out of, related to, or in any way connected with, this letter agreement, your employment with the Company (the “Disputes”) will be governed by State of New York law, excluding laws relating to conflicts or choice of law.

  (d)Electronic Delivery.  The Company may, in its sole discretion, decide to deliver any documents or notices related to this Agreement, securities of the Company or any of its affiliates or any other matter, including documents and/or notices required to be delivered to you by applicable securities law or any other law or the Company’s Certificate of Incorporation or Bylaws by email or any other electronic means.  You hereby consent to (i) conduct business electronically, (ii) receive such documents and notices by such electronic delivery and (iii) sign documents electronically and agree to participate through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.  

  (e)Other Advisory Roles. During your employment with MindMed, you may continue your advisory roles on boards or advisory boards so long as there is no actual or appearance of conflict of interest and the Company has provided pre-clearance approval. The Company approves your advisory roles at XXXXXXXXXX XXXXXXXXXX XXXXXX X X XXXXXXXXXX. 

   

  [Signature Page Follows]

  OL 2021.11.23

  

  DocuSign Envelope ID: C7648EEF-BCE5-48C4-B78C-E3D684BB9F7F

  If you wish to accept this offer, please sign and date both this letter and the enclosed Proprietary Information and Inventions Agreement and return them to me.  As required, by law, your employment with the Company is also contingent upon your providing legal proof of your identity and authorization to work in the United States.  This offer, if not accepted, will expire at the close of business on December 1, 2021.  

   

  We look forward to having you join us. Your employment shall be effective as of December 6, 2021. 

   

  Sincerely,

   

   

  			
	MIND MEDICINE (MINDMED), INC.

	By:
	 
	/s/ Rob Barrow 

	 
	 
	(Signature)

	 
	 
	 

	Name: 
	 
	Rob Barrow 

	Title: 
	 
	Chief Executive Officer

   

  ACCEPTED AND AGREED

   

  Cynthia Hu

   

  	
	/s/ Cynthia hu

	(Signature)

	12/1/2021

  Date

   

  Start Date: 12/06/2021

   

  Attachment A:  Proprietary Information and Inventions Agreement

   

  OL 2021.11.23

  

  DocuSign Envelope ID: C7648EEF-BCE5-48C4-B78C-E3D684BB9F7F

  ATTACHMENT A

  PROPRIETARY INFORMATION AND
INVENTIONS AGREEMENT

  (See Attached)

  260322894

  OL 2021.11.23EX-10.10

   

  Exhibit 10.10

  	
	 

   

  ESCROW AGREEMENT

   

  among

   

  Mind Medicine (MindMed) Inc. and

  Odyssey Trust Company

   

  and

   

  Each of the Undersigned Securityholders

   

   

  	
	 

   

  February 26, 2021

   

   

  

  P a g e  | 2

   

  ESCROW AGREEMENT

  THIS ESCROW AGREEMENT (the “Agreement”) is made as of the 26th day of February, 2021.

  AMONG:

  MIND MEDICINE (MINDMED) INC., a corporation existing under the laws of the Province of British Columbia (the “Corporation”)

  - and -

  ODYSSEY TRUST COMPANY, a corporation existing under the laws of the Province of Alberta (the “Escrow Agent”)

  - and -

  EACH OF THE UNDERSIGNED SECURITYHOLDERS OF THE CORPORATION (a “Securityholder” or collectively, the “Securityholders”)

  WHEREAS:

  A.	This Escrow Agreement is being entered into pursuant to an agreement and plan of merger and reorganization (the “Merger Agreement”) entered into on February 17, 2021 among the Corporation, MindMed Mergerco Inc. (“Merger Sub”), Healthmode, Inc. (“Healthmode”), the Major Stockholders (as defined in the Merger Agreement) and Daniel Karlin (in the capacity of Stockholder Representative (as defined in the Merger Agreement), pursuant to which, among other things, the parties agreed to merge Merger Sub with and into Healthmode (the “Merger”) such that Healthmode will continue as the surviving corporation of the Merger and a wholly owned subsidiary of the Corporation;

  B.	Pursuant to Section 2.6(a) of the Merger Agreement, the Sellers, other than the Cash Out Stockholders (as defined in the Merger Agreement), directed the Corporation to issue an aggregate of 81,497 multiple voting shares in the capital of the Corporation (the “Escrowed Shares”) to the Securityholders as partial consideration for the Merger;

  C.	Pursuant to the terms of the Merger Agreement, the Corporation requires, and the Securityholders have agreed, that all of the Escrowed Shares shall be deposited and held in escrow pursuant to the terms of this Escrow Agreement; and

  F.	The parties hereto wish to appoint the Escrow Agent as escrow agent for the Escrowed Shares and the Escrow Agent has agreed to undertake and perform its duties in accordance with the terms and conditions of this Agreement.

  NOW THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, the parties agree as follows:

   

  

  P a g e  | 3

   

  1.	Escrow

  1.1	The Corporation hereby places and deposits in escrow with the Escrow Agent the Escrowed Shares and hereby delivers to the Escrow Agent the certificates identified in Schedule “A” representing the Escrowed Shares. If at any time for any reason a replacement certificate or replacement certificates are issued representing the Escrowed Shares or if the Escrowed Shares are converted or exchanged into shares of another class, series or company, the Corporation shall deliver such replacement certificate or certificates, or the certificates representing the shares in another class, series or new company, to the Escrow Agent. While the Escrowed Shares are in escrow, the Securityholders shall be entitled to all rights as the beneficial and registered owner of the Escrowed Shares including, without limitation, the right to vote and to receive all dividends and other distributions on the Escrowed Shares.

  1.2	The Escrowed Shares and the beneficial ownership of or any interest in, and the certificates representing, the Escrowed Shares shall not be transferred, gifted, sold, assigned, mortgaged, pledged, hypothecated, alienated, released from escrow, transferred within escrow, or otherwise dealt with in any manner except as expressly provided in section 5.

  1.3	Each of the Securityholders hereby directs the Escrow Agent to retain the Escrowed Shares and the certificates representing the Escrowed Shares and not to do or cause anything to be done to release the Escrowed Shares from escrow or to allow any transfer, gift, assignment, mortgage, pledge, hypothecation or alienation thereof except as expressly provided in section 5.

  1.4	The Corporation hereby acknowledges the terms and conditions of this Agreement and agrees to take all reasonable steps to facilitate its performance.

  1.5	The Corporation shall pay the Escrow Agent the fees for acting as escrow agent.

  2.	Reserved

  3.	Appointment

  3.1	Odyssey Trust Company is hereby appointed, and agrees to act, as Escrow Agent for the receipt of the Escrowed Shares and subject to the terms and conditions of this Agreement.

  4.	Escrow Agent

  4.1	The Escrow Agent is hereby authorized and directed to take delivery of, and to hold, the Escrowed Shares at its offices in Toronto, Ontario or Calgary, Alberta pursuant to the terms of this Agreement.

  5.	Release of Escrowed Shares

  5.1	The Escrowed Shares shall be held in escrow by the Escrow Agent until such Escrowed Shares shall be released from escrow in accordance with the escrow release schedule set forth in:

   

  

  P a g e  | 4

   

  (a)Schedule “B” in the case of Escrowed Shares registered to XXXXXX and XXXXXXX (together, the “Noteholder Escrowed Parties”); and

  (b)Schedule “C” in the case of the Escrowed Shares registered to the Securityholders other than the Noteholder Escrowed Parties (collectively, the “Equityholder Escrowed Parties).

  5.2	Despite any other provision in this Agreement, the Escrow Agent is hereby irrevocably authorized and directed to release the Escrowed Shares:

  (a)upon receipt of a written direction from the Corporation (as authorized by the board of directors of the Corporation) directing the Escrow Agent to deal with the Escrowed Shares in such manner as set out therein;;

  (b)upon receipt of a notarial copy of a court order of a court of competent jurisdiction directing the Escrow Agent to deal with the Escrowed Shares, or any part thereof, in such manner as the court deems fit, which order has not been appealed and which order shall be deemed to be full and sufficient authority to deal with the Escrowed Shares in the manner and on the terms set forth therein; or

  (c)if the Escrow Agent is terminated or resigns as contemplated in sections 7.1(d) and (e), the Escrow Agent shall forthwith transfer the Escrowed Shares to the succeeding escrow agent.

  5.3	To the extent a release from escrow of Escrowed Shares could result in a fractional Escrowed Share, such fractional Escrowed Share shall only be released from escrow in combination with other fractional Escrowed Shares that would result in a whole number of Escrowed Shares. No fractional Escrowed Shares shall be released from escrow.

  5.4	Immediately upon the release from escrow of Escrowed Shares, the Escrow Agent shall deliver to each of the Securityholders thereto all share certificates representing the released Escrowed Shares.

  6.	Reimbursement of Expenses

  6.1	The Escrow Agent will be entitled to reimbursement from the Corporation for all reasonable out-of-pocket expenses incurred by the Escrow Agent in connection with the performance of its duties under this Agreement. The Escrow Agent shall provide the Corporation with an itemized statement for amounts claimed pursuant to this subsection.

  7.	The Escrow Agent

  7.1	The parties acknowledge and agree that:

  (a)the duties and obligations of the Escrow Agent shall be determined solely by the provisions of this Agreement and, accordingly, the Escrow Agent shall not be responsible except for the 

   

  

  P a g e  | 5

   

  performance of such duties and obligations as the Escrow Agent has undertaken in this Agreement;

  (b)the Escrow Agent shall not be responsible for any error in judgement or for any act done or step taken or omitted to be taken by the Escrow Agent in good faith or for any mistake, in fact or law, or for anything which the Escrow Agent may do or refrain from doing in connection with this Agreement except arising out of the Escrow Agent’s own gross negligence or willful misconduct;

  (c)if there is any question as to any of the provisions of this Agreement or the Escrow Agent’s duties under this Agreement, the Escrow Agent shall have the right to consult with and obtain advice from legal counsel appointed by the Escrow Agent, who may but need not be legal counsel for any of the parties to this Agreement, and the Escrow Agent shall incur no responsibility and shall be fully protected in acting in good faith in accordance with any opinion or instruction of such counsel; the Corporation shall pay the reasonable fees, expenses and disbursements of any such counsel so retained by the Escrow Agent;

  (d)the Escrow Agent may resign its trust and be discharged from all duties and obligations under this Agreement by giving not less than 20 days’ advance notice to the Corporation and the Securityholders;

  (e)if the Escrow Agent resigns as escrow agent or is removed in accordance with this Agreement, the Corporation shall have the right and obligation to appoint a succeeding escrow agent who, in each case, upon accepting such appointment shall assume all of the obligations and responsibilities and shall be entitled to enjoy the benefits and rights of the Escrow Agent under this Agreement (and, if a successor escrow agent is appointed as provided in this Agreement, the Escrow Agent is to deliver to such successor certificates representing the Escrowed Shares then in its possession upon payment by the Corporation of the Escrow Agent’s outstanding fees and expenses, if any);

  (f)the Escrow Agent shall not be required to make any determination or decision with respect to the validity of any claim made by any party or of any denial thereof but shall be entitled to rely conclusively on the terms of this Agreement and the documents tendered to it in accordance with the terms of this Agreement;

  (g)if there is any disagreement between the parties to this Agreement resulting in adverse claims or demands with respect to the Escrowed Shares, the Escrow Agent shall be entitled, at its option, to refuse to comply with any claims or demands on it with respect to the Escrowed Shares as long as such disagreement shall continue, and in so refusing, the Escrow Agent may elect to make no delivery of the Escrowed Shares; in so doing, the Escrow Agent shall not be or become liable in any way to the Corporation or the Securityholders for the Escrow Agent’s failure or refusal to comply with such claims or demands;

  (h)if there is any disagreement or apparent disagreement between the parties to this Agreement resulting in adverse claims or demands with respect to the Escrowed Shares or if any of the parties to this Agreement, including the Escrow Agent, are in or appear to be in disagreement about the interpretation of this Agreement or about the rights and obligations of the Escrow Agent or the propriety of an action contemplated by the Escrow Agent under this Agreement, the Escrow Agent may, at its option, or shall by direction of the Corporation or the Securityholders, deposit the 

   

  

  P a g e  | 6

   

  Escrowed Shares or any part thereof then in the Escrow Agent’s possession with a court of competent jurisdiction in Toronto, Ontario and seek instruction or direction from a court of competent jurisdiction, which direction may include a request for an interpleader order and the Corporation and Securityholders (as the case may be) shall indemnify the Escrow Agent in any such action, interpleader or any other action or proceeding for all costs, expenses and fees in its capacity as escrow agent in connection with any deposit or any action brought in connection with this Agreement;

  (i)the Securityholders and the Corporation acknowledge and agree that the Escrow Agent shall be entitled to represent itself in connection with any legal actions taken in connection with this Agreement; and

  (j)upon the Escrow Agent’s delivery of the Escrowed Shares, the Escrow Agent shall be automatically and immediately released from all obligations under this Agreement to any other party to this Agreement and to any other person with respect to the Escrowed Shares, other than obligations existing as of the date of such delivery of the Escrowed Shares.

  8.	Miscellaneous

  8.1	This Agreement may be terminated at any time by and upon written agreement signed by all of the parties and upon delivery to the Escrow Agent of a joint written direction signed by the Corporation and the Securityholders directing the Escrow Agent as to disposal of the Escrowed Shares. Unless so terminated, this Agreement shall terminate upon release by the Escrow Agent of all the Escrowed Shares to the Corporation or the Securityholders, as the case may be, in accordance with section 5.

  8.2	Each party shall promptly do, execute, deliver or cause to be done, executed and delivered all such further acts, documents and things in connection with this Agreement as the other parties may reasonably require for the purposes of giving effect to this Agreement.

  8.3	This Agreement constitutes the entire agreement between the parties hereto pertaining to the subject-matter hereof and supersedes all prior agreements, undertakings, negotiations and discussions, whether oral or written. For greater certainty, all prior agreements between the Corporation and the Securityholders and the Escrow Agent pertaining to the escrow or purchase of any shares of the Corporation held by the Securityholders, excluding any shareholders’ agreement (which includes, for greater certainty, the Merger Agreement which shall continue in force and effect, unamended by this Escrow Agreement, in accordance with its terms) concerning the Corporation to which the Securityholders are bound, are hereby terminated and superseded by this Agreement. There are no conditions, warranties, representations or other agreements between the parties in connection with the subject matter hereof (whether oral or written, implied or express, statutory or otherwise) except as specifically set forth in this Agreement.

  8.4	No amendment of this Agreement shall be effective unless made in writing and signed by the parties.

  8.5	Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability and shall be severed from the balance of this Agreement, all without invalidating the remaining provisions hereof or affecting the validity or enforceability of such provision in any other jurisdiction.

   

  

  P a g e  | 7

   

  8.6	No waiver by any party of any default, breach or non-compliance by any other party under this Agreement shall operate as a waiver of such party’s rights under this Agreement in respect of any continuing or subsequent default, breach or non-compliance by such other party under this Agreement shall operate as a waiver of such party’s rights under this Agreement in respect of any continuing or subsequent default, breach or non-observance (whether of the same or any other nature). To be effective, any such waiver must be in writing and signed by the party to be bound thereby. No waiver shall be inferred from or implied by any failure to act or delay in acting by any party in respect of any such default, breech or non-observance or by anything done or omitted to be done by any party with respect thereto.

  8.7	This Agreement shall enure to the benefit of and be binding upon the parties and each of their respective heirs, estate trustees, legal personal representatives, successors and assigns.

  8.8	Each of the Corporation and the Securityholders shall jointly and severally indemnify and hold the Escrow Agent, its partners, associates, employees and agents harmless against any loss, liability or expense incurred by the Escrow Agent as a consequence of its acting as escrow agent pursuant to the terms of this Agreement save and except for the gross negligence, bad faith or willful misconduct of the Escrow Agent, its partners, associates, employees or agents in connection with the administration of its duties under this Agreement, such indemnification to include the costs and expenses of the Escrow Agent’s defence against any claim or liability in connection therewith. Despite section 8.1, the provisions of this section shall survive any termination of this Agreement.

  8.9	Any notice, consent, waiver or other communication given under this Agreement must be in writing and may be given by delivering it, or by sending it by facsimile or electronic communication in accordance with the Asset Purchase Agreement or if to the Escrow Agent to:

  Odyssey Trust Company

  Stock Exchange Tower

  Suite 1239, 300 5th Ave S.W.,

  Calgary, Alberta T2P 3C4

  Email:	XXXXXXXXXXXXXXXX

  Attention:	XXXXXX

  Any such communication is deemed to have been delivered and received on the date of personal delivery or transmission, as applicable, if such day is a business day and such delivery or transmission was received by the recipient party prior to 5:00 p.m. (Toronto time) and otherwise on the next business day. Any party may change its address for service by notice given in accordance with the foregoing and any subsequent notice shall be sent to such Person at its changed address.

  8.10	This Agreement shall be governed by and construed in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein.

  8.11	The parties hereby (i) irrevocably and unconditionally attorn and submit to the non-exclusive jurisdiction of the courts of the Province of Ontario with respect to any legal action or proceeding relating to this Agreement; (ii) irrevocably waive and agree not to assert, in any such legal action or proceeding, any objection they may now or 

   

  

  P a g e  | 8

   

  hereafter have to the laying of venue of any legal action or proceeding in such courts including, without limitation, any objection that such courts are an inconvenient forum; and (iii) agree not to assert that any judgment or order duly obtained against them in any action or proceeding brought in any such court should not be enforced in any other court which has jurisdiction, by registration of said judgment or order, or by any other means available for enforcement of judgments or orders.

  8.12	This Agreement may be executed by the parties by facsimile and in separate counterparts each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument.

  [INTENTIONALLY BLANK]

   

  

  P a g e  | 9

   

  IN WITNESS WHEREOF the Parties hereto have executed this Escrow Agreement as of the date first above written.

   

  			
	Mind Medicine (MindMed) Inc.

	 
	 
	 

	Per:
	 
	/s/ Dave GueBert

	Name:
	 
	Dave GueBert

	Title:
	 
	Chief Financial Officer

   

  			
	Odyssey Trust Company

	 
	 
	 

	Per:
	 
	 

	Name:
	 
	 

	Title:
	 
	 

	 
	 
	 

	Per:
	 
	 

	Name:
	 
	 

	Title:
	 
	 

   

  			
	Major Stockholders

	 
	 
	 

	Per: 
	 
	 

	 
	 
	Daniel Karlin

	 
	 
	 

	Per:
	 
	 

	 
	 
	Bradford Cross

   

  			
	Securityholders Other than Major Stockholders and Noteholders Escrow Parties

	 
	 
	 

	Per:
	 
	 

	 
	 
	Daniel Karlin, as Stockholder Representative

   

   

  

  P a g e  | 10

   

  IN WITNESS WHEREOF the Parties hereto have executed this Escrow Agreement as of the date first above written.

   

  			
	Mind Medicine (MindMed) Inc.

	 
	 
	 

	Per:
	 
	 

	Name:
	 
	 

	Title:
	 
	 

   

  			
	Odyssey Trust Company

	 
	 
	 

	Per:
	 
	/s/ Dan Sander

	Name:
	 
	Dan Sander

	Title:
	 
	VP, Corporate Trust

	 
	 
	 

	Per:
	 
	/s/ Amy Douglas

	Name:
	 
	Amy Douglas

	Title:
	 
	Director, Corporate Trust

   

  			
	Major Stockholders

	 
	 
	 

	Per: 
	 
	 

	 
	 
	Daniel Karlin

	 
	 
	 

	Per:
	 
	 

	 
	 
	Bradford Cross

   

  			
	Securityholders Other than Major Stockholders and Noteholders Escrow Parties

	 
	 
	 

	Per:
	 
	 

	 
	 
	Daniel Karlin, as Stockholder Representative

   

   

  

  P a g e  | 11

   

  IN WITNESS WHEREOF the Parties hereto have executed this Escrow Agreement as of the date first above written.

   

  			
	Mind Medicine (MindMed) Inc.

	 
	 
	 

	Per:
	 
	 

	Name:
	 
	 

	Title:
	 
	 

   

  			
	Odyssey Trust Company

	 
	 
	 

	Per:
	 
	 

	Name:
	 
	 

	Title:
	 
	 

	 
	 
	 

	Per:
	 
	 

	Name:
	 
	 

	Title:
	 
	 

   

  			
	Major Stockholders

	 
	 
	 

	Per: 
	 
	/s/ Daniel Karlin

	 
	 
	Daniel Karlin

	 
	 
	 

	Per:
	 
	/s/ Bradford Cross

	 
	 
	Bradford Cross

   

  			
	Securityholders Other than Major Stockholders and Noteholders Escrow Parties

	 
	 
	 

	Per:
	 
	/s/ Daniel Karlin

	 
	 
	Daniel Karlin, as Stockholder Representative

   

   

  

  P a g e  | 12

   

   

  					
	XXXXXXXXX

	on behalf of itself and as nominee for
certain affiliated entities

	XXXXXXXXXXX

	XXXXXXX

	 
	 
	Per:
	 
	X

	 
	 
	Name:
	 
	XXXXX

	 
	 
	Title:
	 
	XXXXXXX

	 
	 
	 
	 
	 

	XXXXXXXXX

	By:
	 
	XXXXX

	Its:
	 
	XXXXXX

	 
	 
	Per:
	 
	X

	 
	 
	Name:
	 
	XXXXXX

	 
	 
	Title:
	 
	XXXXXXX

   

   

  

   

  SCHEDULE “A” ESCROWED SHARES

   

  Noteholder Escrowed Parties:

   

  			
	Name of Registered Holder
	No. of Escrowed Shares
	Certificate No.

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XX
	 

	 
	 
	 

	 
	 
	 

	TOTAL
	32,703
	 

   

   

   

  

  P a g e  | 2

   

  Equityholder Escrowed Parties:

   

   

  			
	Name of Registered Holder
	No. of Escrowed Shares
	Certificate No.

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

	XXXXXXXX
	XXX
	 

   

  TOTAL	48,794

   

  

   

  SCHEDULE “B”

  NOTEHOLDER ESCROWED PARTIES RELEASE SCHEDULE

   

  Timed Release

   

  			
	 
Release Dates
	Percentage of Total Escrowed
Securities to be Released
	Total Number of Escrowed
Securities to be Released

	July 1, 2021
	50%
	16,352

	January 1, 2022
	50%
	16,351

	TOTAL
	100%
	32,703

   

   

  

   

  SCHEDULE “C”

  EQUITYHOLDER ESCROWED PARTIES RELEASE SCHEDULE

   

  Timed Release

   

  			
	 
Release Dates
	Percentage of Total Escrowed
Securities to be Released
	Total Number of Escrowed
Securities to be Released

	July 1, 2021
	33.34%
	16,264

	January 1, 2022
	33.33%
	16,264

	September 1, 2022
	33.33%
	16,266

	TOTAL
	100%
	48,794

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]